NMRA stock rated a Buy by Guggenheim

Anna Perez

In a filing, Neumora Therapeutics Inc revealed its insider Aurora Daljit Singh unloaded Company’s shares for reported $0.31 million on Nov 11 ’25. In the deal valued at $2.68 per share,114,703 shares were sold. As a result of this transaction, Aurora Daljit Singh now holds 0 shares worth roughly $0.0.

Then, Aurora Family Trust bought 114,703 shares, generating $307,027 in total proceeds.

Before that, Burow Kristina bought 1,915,700 shares. Neumora Therapeutics Inc shares valued at $4,999,977 were divested by the Director at a price of $2.61 per share. As a result of the transaction, Burow Kristina now holds 6,046,907 shares, worth roughly $16.02 million.

Guggenheim upgraded its Neumora Therapeutics Inc [NMRA] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid September from “a Neutral” to “an Underweight”. BofA Securities also remained covering NMRA and has decreased its forecast on April 02, 2025 with a “an Underperform” recommendation from previously “Buy” rating. William Blair revised its rating on March 10, 2025. It rated NMRA as “a Mkt perform” which previously was an “an Outperform”.

Price Performance Review of NMRA

On Friday, Neumora Therapeutics Inc [NASDAQ:NMRA] saw its stock fall -1.49% to $2.65. Over the last five days, the stock has gained 3.52%. Neumora Therapeutics Inc shares have fallen nearly -76.57% since the year began. Nevertheless, the stocks have fallen -75.00% over the past one year. While a 52-week high of $11.97 was reached on 10/31/25, a 52-week low of $0.61 was recorded on 05/14/25.

Levels Of Support And Resistance For NMRA Stock

The 24-hour chart illustrates a support level at 2.56, which if violated will result in even more drops to 2.47. On the upside, there is a resistance level at 2.76. A further resistance level may holdings at 2.88.

How much short interest is there in Neumora Therapeutics Inc?

A steep rise in short interest was recorded in Neumora Therapeutics Inc stocks on 2025-10-31, dropping by -0.23 million shares to a total of 6.54 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 6.78 million shares. There was a decline of -3.56%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.